Raul Manuel Hernandez, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 851 W Foothill Blvd Ste 101, Rialto, CA 92376 Phone: 909-873-3876 Fax: 909-873-3875 |
Delfin Leonardo Dano, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1850 N Riverside Ave, Suite 210, Rialto, CA 92376 Phone: 909-562-0012 |
Emmanuel Obiajulu Unachukwu, M.D Pediatrics Medicare: Medicare Enrolled Practice Location: 425 E Foothill Blvd, Rialto, CA 92376 Phone: 909-546-1050 Fax: 909-546-1061 |
Jocelyn Arevalo Mcgrath, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1851 N Riverside Ave, Rialto, CA 92376 Phone: 909-871-2371 Fax: 909-874-0826 |
Dr. Alberto Marcelino Cruz, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 195 E Foothill Blvd, Rialto, CA 92376 Phone: 909-874-3490 Fax: 909-874-3470 |
News Archive
Dartmouth's Geisel School of Medicine and Aeras, a global nonprofit biotech, announced a collaboration to jointly conduct a trial of a new vaccine against tuberculosis (TB), one of the world's deadliest diseases. The vaccine, known as DAR-901, is related to the vaccine SRL-172, previously shown by Dartmouth investigators to decrease the risk of TB in a trial known as the DarDar Trial.
There's something off - something a bit cowardly, actually - about the positions of both parties in the abortion debate refueled by the asinine remarks of Rep. Todd Akin (R-Mo.). Akin's comments have left Republicans scrambling to avoid the politically unpalatable implications of the anti-abortion views central to their party.
The University of Florida Research Foundation Inc. (UFRF) has filed a lawsuit in United States federal district court in Florida against Diamyd Medical claiming that UFRF is entitled to a percentage of the license fee paid to Diamyd Medical by Ortho-McNeil-Jansen Pharmaceuticals, Inc. (OMJPI).
Graft size, sex and age have a significant effect on the odds of an ACL re-tear post reconstruction with a hamstring graft, say researchers presenting their work today at the American Orthopaedic Society of Sports Medicine's (AOSSM) Annual Meeting in Colorado Springs, CO.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, today announced that it received a complaint filed by Celgene Corporation seeking a declaration from the court that four Cyclacel-owned patents, which claim the use of romidepsin injection in T-cell lymphomas, are not infringed by Celgene's products and are invalid.
› Verified 2 days ago